About one in eight Americans have tried GLP-1 drugs like Mounjaro, Zepbound and Ozempic — and they’ve shrunken appetites so dramatically that people are spending noticeably less on groceries. But one dietitian and LillyDirect partner — a platform from Eli Lilly, which sells Mounjaro and Zepbound — tells The Post there are actually lots of...